PT Kalbe Farma Tbk. (PTKFF)

USD 0.08

(0.0%)

Total Assets Summary of PT Kalbe Farma Tbk.

PT Kalbe Farma Tbk.'s latest annual total assets in 2023 was 1.75 Billion USD , up 0.88% from previous year.
PT Kalbe Farma Tbk.'s latest quarterly total assets in 2024 Q2 was 1.74 Billion USD , down -4.49% from previous quarter.
PT Kalbe Farma Tbk. reported annual total assets of 1.74 Billion USD in 2022, down -2.96% from previous year.
PT Kalbe Farma Tbk. reported annual total assets of 1.79 Billion USD in 2021, up 11.87% from previous year.
PT Kalbe Farma Tbk. reported quarterly total assets of 1.82 Billion USD for 2024 Q1, up 3.74% from previous quarter.
PT Kalbe Farma Tbk. reported quarterly total assets of 1.74 Billion USD for 2024 Q2, down -4.49% from previous quarter.

Annual Total Assets Chart of PT Kalbe Farma Tbk. (2023 - 2015)

Historical Annual Total Assets of PT Kalbe Farma Tbk. (2023 - 2015)

Year	Total Assets	Total Assets Growth
2023	1.75 Billion USD	0.88%
2022	1.74 Billion USD	-2.96%
2021	1.79 Billion USD	11.87%
2020	1.6 Billion USD	10.02%
2019	1.45 Billion USD	15.68%
2018	1.26 Billion USD	3.04%
2017	1.22 Billion USD	8.37%
2016	1.13 Billion USD	13.75%
2015	993.57 Million USD	0.0%

Year	Total Assets	Total Assets Growth
2024 Q3	1.89 Billion USD	1649926.7%
2024 Q1	1.82 Billion USD	3.74%
2024 Q2	1.74 Billion USD	-4.49%
2023 Q3	1.76 Billion USD	-3.83%
2023 FY	1.75 Billion USD	0.88%
2023 Q2	1.83 Billion USD	-1.43%
2023 Q1	1.86 Billion USD	6.9%
2023 Q4	1.75 Billion USD	-0.46%
2022 Q4	1.74 Billion USD	2.43%
2022 FY	1.74 Billion USD	-2.96%
2022 Q3	1.7 Billion USD	0.56%
2022 Q1	1.85 Billion USD	3.16%
2022 Q2	1.69 Billion USD	-8.68%
2021 Q1	1.64 Billion USD	0.0%
2021 FY	1.79 Billion USD	11.87%
2021 Q3	1.69 Billion USD	5.23%
2021 Q4	1.79 Billion USD	5.77%
2021 Q2	1.61 Billion USD	-2.02%
2020 FY	1.6 Billion USD	10.02%
2019 FY	1.45 Billion USD	15.68%
2018 FY	1.26 Billion USD	3.04%
2017 FY	1.22 Billion USD	8.37%
2016 FY	1.13 Billion USD	13.75%
2015 FY	993.57 Million USD	0.0%

Peer Total Assets Comparison of PT Kalbe Farma Tbk.

Name	Total Assets	Total Assets Difference
AstraZeneca PLC	100.97 Billion USD	98.258%
Bristol-Myers Squibb Company PFD CONV 2	95.15 Billion USD	98.152%
CSPC Pharmaceutical Group Limited	6.52 Billion USD	73.042%
Clarus Therapeutics Holdings, Inc.	51.7 Million USD	-3301.296%
Novartis AG	99.94 Billion USD	98.24%